Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesProsthetics & OrthoticsSierra Health and Life lower extremity prosthetics…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Currentsierra health and lifePolicy 2026T0645N

    Lower Extremity Prosthetics

    Customize your policy alerts

    Sign up for sierra health and life Policy 2026T0645N alerts

    Get alerted when Policy 2026T0645N changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Clinical coverage policy for lower extremity prosthetic devices for UnitedHealthcare Commercial and Individual Exchange members, describing medical necessity, definitions, and applicable billing codes.

    Policy Summary
    Payersierra health and life
    PolicyLower Extremity Prosthetics
    Policy CodePolicy 2026T0645N
    Change TypeUpdated evidence & references (non‑material)
    Effective DateAug 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateN/A
    Key ActionObtain and submit InterQual documentation and member-specific benefit information when requesting authorization.
    SourceLink
    POLICY UPDATE CHANGES

    Updated Clinical Evidence and References sections to reflect the most current information and archived previous policy version 2026T0645M.

    InterQual referencedInterQual referenced
    Not medically necessaryBone-anchored prostheses
    K1/K2 = N/MNMPK restriction (K1/K2)
    ~120+HCPCS L-codes listed
    external onlyCoverage scope

    Coverage Criteria and Evidence-based Stances

    General coverage stance

    Covered when meeting InterQual criteria and member-specific benefits

    General: A lower extremity prosthetic for amputations is proven and medically necessary in certain circumstances; coverage decisions rely on meeting the InterQual CP: Durable Medical Equipment, Prosthetics, Lower Extremity clinical criteria and the member's specific benefit plan document.

    See InterQual criteria for component- and condition-level requirements; providers should submit required documentation to demonstrate InterQual criteria are met.

    Not medically necessary / Unproven devices

    The following are explicitly stated as unproven and not medically necessary

    Bone-anchored prostheses: Bone-anchored percutaneous limb prostheses (e.g., Osseoanchored Prostheses for the Rehabilitation of Amputees [OPRA] Implant System) are unproven and not medically necessary due to insufficient evidence of efficacy.

    Requests are at risk of denial; see clinical evidence for high complication and revision rates.

    Policy Summary
    Payersierra health and life
    PolicyLower Extremity Prosthetics
    Policy CodePolicy 2026T0645N
    Change TypeUpdated evidence & references (non‑material)
    Effective DateAug 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateN/A
    Key ActionObtain and submit InterQual documentation and member-specific benefit information when requesting authorization.
    SourceLink
    On This Page
    Coverage Criteria and Evidence-based StancesApplicable Billing Codes and ClassificationPrior Authorization, Documentation, and Operational GuidanceClinical Background and ScopeKey Definitions and TermsPolicy Revision History
    Microprocessor knee restriction (K1/K2): Endoskeletal microprocessor-controlled knee-shin systems with swing/stance phase control are unproven and not medically necessary for amputees with MFCL K1 or K2, including transfemoral (AK), knee disarticulation, hip disarticulation, or hemipelvectomy.MFCL = K1 or K2

    Applies to the listed amputation levels per policy.

    Combined microprocessor ankle-foot with power assist: A combined microprocessor-controlled ankle-foot system with power assist is unproven and not medically necessary due to insufficient evidence of efficacy.

    Applies across applicable amputation levels as specified in the policy.

    Initial or replacement prosthetic device coverage

    Covered when ALL of the following are met

    Primary coverage criteria: The prosthetic device replaces a limb or body part (external prosthetic such as artificial arms, legs, feet, hands); The device is medically necessary as defined in the member's specific benefit plan document; The device is not subject to a coverage exclusion in the member's specific benefit plan document.

    Benefits are provided only for external prosthetic devices; internal/fully implanted devices are covered under medical/surgical benefits.

    Device selection and payment limitation

    When multiple devices can meet needs

    Device selection: If more than one prosthetic device can meet the member's functional needs, benefits cover only the device that meets the minimum specifications for those needs; if the member elects an upgraded device, payment is limited to the amount that would have been paid for the minimum-spec device and the member is responsible for the cost difference.

    Apply member cost-sharing for upgrades; verify member-specific plan terms.

    Coverage-relevant clinical criteria (evidence summary)

    Evidence-derived considerations relevant to coverage decisions

    Bone-anchored transfemoral prostheses considerations: Studies typically selected skeletally mature transfemoral amputees with prior socket prosthesis intolerance or problems and used staged surgical approaches and rehabilitation protocols; many trials excluded patients with severe peripheral vascular disease or diabetes. While patient-reported outcomes often improved, studies reported high rates of deep infection, osteomyelitis, mechanical complications, and revisions, limiting generalizability and raising safety concerns.

    Balance documented PRO improvements against substantial complication and revision rates when considering coverage or prior authorization.

    Microprocessor knee considerations: Microprocessor knees (MPKs) demonstrate improved safety, balance confidence, walking speed, and patient-reported outcomes in K3/K4 community ambulators and selected K2 limited community ambulators in trials and systematic reviews; evidence is limited for lower functional levels and small study sizes and methodological limits are common.

    Trial fittings and documented functional gains (reduced falls, increased gait speed, improved PROMs) are suggested to justify provision in borderline cases.

    Microprocessor Knee (MPK) coverage criteria (evidence-based suggested)

    Evidence supports use when ALL/conditional criteria met (per studies and clinical recommendations):

    MPK candidate criteria: Patient's MFCL/K-level and functional goals align with populations showing benefit (e.g., limited community ambulators MFCL-2 or higher in many studies); documented trial fitting with an MPK that demonstrates objective or patient-reported improvement in safety (reduced falls), walking speed, balance confidence, or validated PROMs compared to the prior device; patient medically stable and able to participate in acclimation and training; documented pre- and post-trial outcome measures (e.g., PEQ, Q-TFA, gait speed, ADLs).see cited studies for reported effect sizes (e.g., 14%-25% faster walking in some MPK trials)

    Derived from systematic reviews, randomized and crossover trials recommending individualized trial fittings and outcome documentation prior to authorization.

    Powered Ankle (MPA/PwrAF) stance

    Evidence is limited and inconsistent; consider as experimental/ investigational unless demonstrated benefit

    Powered ankle evidence considerations: Current literature is insufficient to conclusively demonstrate effectiveness of powered microprocessor prosthetic ankles (MPAs/PwrAF) for transtibial amputations; small comparative studies and survey data report possible subgroup improvements in walking speed, pain, or perceived mobility but results are inconsistent and many users have reverted to passive feet—provision should require documented, objective functional improvement for the individual.no standardized numeric threshold established

    Hayes reviews and small studies identify inconsistent results, recall bias, small samples, and inability to predict responders; individual trial documentation preferred before coverage.

    Powered Hip Prosthesis (prototype) stance

    Prototype / early-stage evidence:

    Powered hip prosthesis: Evidence for microprocessor-controlled powered hip prostheses is limited to prototype development, bench testing, and small able-bodied simulator studies; while initial mechanical tests met many design criteria, control systems and evaluation in target amputee populations are incomplete, and further development and clinical studies are required before clinical coverage can be considered.n/a

    Current data derive from mechanical validation and three able-bodied participant functional tests; additional human clinical trials are needed.

    Requests for bone-anchored percutaneous limb prostheses (for example, the OPRA Implant System) are considered unproven and not medically necessary due to insufficient evidence of efficacy. This exclusion applies to requests for implantation unless clear, higher-quality evidence establishes safety and durable clinical benefit over conventional socket-suspended prostheses.

    Coverage excludes devices provided solely as safety items or to enhance sports-related performance. Repair or replacement requests resulting from misuse, malicious damage, gross neglect, or to replace items that are lost or stolen are not covered under this policy.

    Many published OPRA studies explicitly excluded patients with conditions that impair healing, most commonly severe peripheral vascular disease and/or diabetes mellitus. Because these populations were not included in the primary cohorts, evidence on OPRA’s safety and effectiveness does not generalize to patients with these comorbidities.

    Current evidence for powered microprocessor prosthetic ankles is limited and inconsistent. The literature does not provide sufficient, high-quality data to support routine coverage for transtibial amputees; available studies are small, often uncontrolled, and show mixed functional results, so routine provision is not supported without documented individual benefit.

    The evidence base for powered ankle systems and other advanced prosthetic components is limited by methodological issues including recall bias in survey-based studies, small sample sizes, and unrepresentative samples (for example, all-male responders). These limitations reduce generalizability and impede identification of patient characteristics that predict benefit.

    Endoskeletal microprocessor-controlled knee-shin systems that provide variable swing and stance phase control are considered not medically necessary for members functionally classified as K1 or K2. This restriction reflects insufficient evidence of efficacy for low functional-level ambulators.

    Use of the OPRA system for transfemoral amputees is not supported by sufficient high-quality evidence. Observational cohorts report mobility gains but also high rates of deep infection, osteomyelitis, mechanical complications, and frequent revisions, raising concerns about the procedure’s safety profile in this population.

    Overall evidence for bone-anchored percutaneous limb prostheses in transfemoral amputees is low quality and inconsistent. Given small study sizes, overlapping cohorts, and frequent serious complications, the literature provides unclear support for routine coverage of these procedures for TF amputees.

    Routine provision of powered microprocessor ankles is not supported by a consistent body of high-quality evidence. Small comparative studies, surveys, and evolving evidence reviews report variable outcomes and frequent device abandonment; therefore, powered ankles may be considered experimental/ investigational unless objective, documented functional improvements are shown for the individual patient.

    In the randomized trial by Kim et al. (2021), there was no significant benefit of a powered prosthesis versus an unpowered prosthesis on metabolic cost, walking speed, physical activity, or perceived mobility. Participants noted concerns about device weight and battery life; the study was limited by small sample size and incomplete real-world data capture.

    Applicable Billing Codes and Classification

    Applicable HCPCS L-codes (partial list)HCPCS
    L5000Partial foot, shoe insert with longitudinal arch, toe filler.
    L5010Partial foot, molded socket, ankle height, with toe filler.
    L5050Ankle, Symes, molded socket, SACH foot.
    L5060Ankle, Symes, metal frame, molded leather socket, articulated ankle/foot (SACH).
    L5100Below knee (BK), molded socket, shin, SACH foot.
    L5105Below knee (BK), plastic socket, joints and thigh lacer, SACH foot.
    L5150Knee disarticulation (or through knee), molded socket, external knee joints, shin, SACH foot.
    L5160Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, SACH foot.
    L5200Above knee (AK), molded socket, single axis constant friction knee, shin, SACH foot.
    L5210Above knee (AK), short prosthesis, no knee joint (stubbies), with foot blocks, no ankle joints, each.
    1–10 of 13
    1/2
    Immediate postsurgical and initial prosthesis HCPCS codes (partial)HCPCS
    L5400Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee (BK).
    L5410Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee (BK), each additional cast change and realignment.
    L5420Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change above knee (AK) or knee disarticulation.
    L5430Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, above knee (AK) or knee disarticulation, each additional cast change and realignment.
    L5450Immediate postsurgical or early fitting, application of nonweight bearing rigid dressing, below knee (BK).
    L5460Immediate postsurgical or early fitting, application of nonweight bearing rigid dressing, above knee (AK).
    L5500Initial, below knee (BK) PTB type socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, direct formed.
    L5505Initial, above knee (AK), knee disarticulation, ischial level socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, direct formed.
    Additions and component HCPCS codes (partial)HCPCS
    L5610Addition to lower extremity, endoskeletal system, above knee (AK), hydracadence system (and related additions).
    L5613Addition to lower extremity, endoskeletal system, above knee (AK), linkage, with hydraulic swing phase control.
    L5614Addition to lower extremity, endoskeletal system, above knee (AK), linkage, with pneumatic swing phase control.
    L5615Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control.
    L5620Addition to lower extremity, test socket, below knee (BK).
    L5637Addition to lower extremity, below knee (BK), total contact.
    L5646Addition to lower extremity, below knee (BK), air, fluid, gel or equal, cushion socket.
    L5686Addition to lower extremity, below knee (BK), back check (extension control).
    Applicable HCPCS/L CodesHCPCS
    L5681Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for (initial only).
    L5682Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for (locking mechanism, initial only).
    L5683Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, initial only.
    L5684Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for (initial only).
    L5685Addition to lower extremity prosthesis, below knee (BK), suspension/sealing sleeve, with or without valve, any material, each.
    L5686Addition to lower extremity, below knee (BK), back check (extension control).
    L5688Addition to lower extremity, below knee (BK), waist belt, webbing.
    L5690Addition to lower extremity, below knee (BK), waist belt, padded and lined.
    L5692Addition to lower extremity, above knee (AK), pelvic control belt, light.
    L5694Addition to lower extremity, above knee (AK), pelvic control belt, padded and lined.
    1–10 of 99
    1/10
    Regulatory / informational (no billing codes listed in this section)mixed
    No codes listed
    Functional classification — K0–K4 per CMS MFCL definitions
    K0 (MFCL-0)No ability or potential to ambulate or transfer safely; prosthesis does not enhance quality of life or mobility.
    K1 (MFCL-1)Ability or potential to use a prosthesis for transfers or ambulation on level surfaces at a fixed cadence (typical household ambulator).
    K2 (MFCL-2)Ability or potential for ambulation with ability to traverse low-level environmental barriers (curbs, stairs, uneven surfaces); limited community ambulator.
    K3 (MFCL-3)Ability or potential for ambulation with variable cadence; typical community ambulator who can traverse most environmental barriers and may have vocational/therapeutic/exercise-related prosthetic needs.
    K4 (MFCL-4)Ability or potential for prosthetic ambulation that exceeds basic skills, exhibiting high impact, stress, or energy levels (typical of children, active adults, or athletes).

    Prior Authorization, Documentation, and Operational Guidance

    Prior Authorization

    Use InterQual criteria and member documentation for coverage decisions

    Coverage decisions rely on InterQual CP criteria and the member-specific benefit plan; obtain and submit the clinical documentation required by InterQual and the member's plan when requesting coverage.

    • Supply medical records demonstrating the member meets InterQual Durable Medical Equipment, Prosthetics, Lower Extremity criteria.
    • Reference and attach the member-specific benefit plan document and any applicable federal or state mandates.
    Prior Authorization

    Obtain prior authorization for listed HCPCS/L-codes

    Prior authorization is implied for the listed HCPCS/L-codes; obtain plan authorization per the member's benefit requirements before providing the device.

    • Include the applicable L-code(s) from the policy's code list with the authorization request.
    • Follow the member-specific prior authorization process and submission requirements.
    Prior Authorization

    Recommend prior authorization and enhanced justification for bone‑anchored TF prostheses

    For osseointegrated (bone‑anchored) transfemoral prostheses, submit a prior authorization with clinical justification, documentation of prior conservative management (socket prosthesis), and informed consent addressing infection and revision risk.

    • Explain prior socket-suspended prosthesis intolerance or failure and prior conservative management.
    • Document informed consent that discusses high rates of infection, mechanical complications, and revisions reported in the literature.
    Documentation Required

    Document trial fitting and measurable benefit

    Consider trial fittings and document objective functional gains (e.g., reduced falls, improved walking speed, balance, or validated PROMs) to support provision of microprocessor knees and other advanced components.

    • Provide pre‑ and post‑trial outcome measures (e.g., Q‑TFA, PEQ, ADAPT, gait speed) showing improvement.
    • Record acclimation period and trial fitting dates and results.
    Note

    Check member-specific coverage rules before submitting requests

    Verify member-specific coverage rules and the member's benefit plan document before applying this policy; the member document governs coverage decisions and any mandates.

    • Confirm whether the device or service is excluded or limited by the member's benefit plan.
    • Check applicable federal or state mandates that could alter coverage.
    Step Therapy

    Follow InterQual-based step guidance where applicable

    Follow InterQual-based guidance for staged or preparatory device requirements; if InterQual criteria indicate staged fitting or preparatory devices, adhere to those stepwise requirements in documentation and authorization requests.

    • Cite the specific InterQual criteria used when submitting clinical documentation.
    • Document staged fitting or preparatory device use if required by InterQual.
    Billing Rule

    Limit benefit to device meeting minimum specifications

    When multiple devices could meet the member's needs, benefits cover the device meeting minimum specifications; if the member chooses an upgraded device, document that the member will pay the difference.

    • Specify the minimum‑spec device and cost baseline in the prior authorization.
    • Include a signed acknowledgement if the member elects an upgraded device and accepts additional cost responsibility.
    Step Therapy

    Expect prior socket‑suspended prosthesis use/failure before osseointegration

    Document prior use and failure or intolerance of conventional socket‑suspended prostheses before proposing osseointegration; literature and study selection criteria support a ‘socket‑first’ expectation.

    • Include records of socket prosthesis problems (pain, skin breakdown, inability to use) and prior treatments tried.
    • Summarize why conventional socket management failed or was intolerable for the member.
    Step Therapy

    No single mandatory step therapy sequence specified

    There is no explicit, uniform step therapy sequence in this policy; selection of prosthetic components should be individualized based on InterQual and clinical judgment.

    • If InterQual specifies steps, follow those criteria; otherwise, individualize device selection and document rationale.
    • Do not assume a mandatory universal stepwise sequence applies absent InterQual or benefit plan language.
    Documentation Required

    Provide medical records showing InterQual criteria are met

    Medical records may be required to verify InterQual criteria; supply documentation that demonstrates how the member meets InterQual Durable Medical Equipment, Prosthetics, Lower Extremity clinical criteria.

    • Include relevant clinical notes, functional assessments, prior device history, and outcomes of any trial fittings.
    • Attach InterQual criteria references or outputs used in the assessment.
    Documentation Required

    Document medical necessity and device replacement rationale

    Provide evidence that the prosthetic device replaces a limb/body part and meets medical necessity per the member's benefit plan when requesting initial or replacement devices.

    • Include the member-specific definition of medical necessity and documentation demonstrating the device replaces a limb or body part.
    • For replacements, document reason for replacement and relate to medical necessity rather than misuse or loss.
    Documentation Required

    Include suggested documentation specific to osseointegration proposals

    When proposing osseointegration, document prior socket issues, functional status, patient‑reported outcome measures (e.g., Q‑TFA, SF‑36), and discuss infection and mechanical complication risks reported in long‑term follow‑up.

    • Attach PROM scores (Q‑TFA, SF‑36) pre‑ and post‑intervention where available.
    • Document discussion of study‑reported risks (deep infection, osteomyelitis, high revision rates) in informed consent.
    Documentation Required

    Document functional status and trial outcomes (K‑level, PROMs, performance tests)

    Document the member's MFCL/K‑level, acclimation and trial fitting outcomes, and validated patient‑reported and performance‑based measures (e.g., ADAPT, PEQ, gait speed) when seeking coverage for microprocessor knees or advanced components.

    • Record the K‑level assessment and how it matches the evidence base (e.g., K2 vs K3/K4).
    • Provide baseline and post‑trial performance measures and PROMs to support functional benefit.
    Denial Risk

    Verify member benefit and applicable mandates

    Verify member benefit terms and any federal/state mandates before finalizing coverage decisions; failure to reference the member's plan document can lead to denial.

    • Confirm exclusions or limitations in the member's specific benefit plan that could bar coverage.
    • Document compliance with any applicable mandates in the prior authorization or appeal.
    Denial Risk

    Bone‑anchored prostheses are considered not medically necessary (denial risk)

    Requests for bone‑anchored percutaneous limb prostheses (e.g., OPRA) are considered unproven and not medically necessary and are at risk of denial unless strong, plan‑allowed clinical justification is provided.

    • If submitted, include high‑quality comparative evidence and justification addressing high revision and infection rates reported in the literature.
    • Expect payor review to categorize OPRA/osseointegration requests as unproven for transfemoral amputees.
    Denial Risk

    MPKs for K1/K2 are not medically necessary (denial risk)

    Requests for microprocessor‑controlled knee systems for members with MFCL K1 or K2 are considered not medically necessary and may be denied.

    • Document the member's K‑level; do not request MPK coverage for K1 or K2 without compelling justification.
    • If K2 candidates are considered, provide trial fitting data and InterQual justification per policy guidance.
    Billing Rule

    Coverage exclusions and member cost responsibility

    If a device or replacement is specifically excluded by the member's benefit plan, the device is not covered; if the member elects an upgraded device, payment is limited to the cost of the minimum‑spec device and the member is responsible for the difference.

    • Check for exclusions (e.g., devices used for sports performance) in the member's plan prior to authorization.
    • Obtain member acknowledgement and cost‑sharing information when an upgraded device is chosen.
    Denial Risk

    Excluded replacement reasons may lead to denial

    Repair or replacement due to misuse, malicious damage, gross neglect, or to replace lost/stolen items may be excluded—document the cause of damage and relate it to covered replacement criteria.

    • If denial is possible, provide documentation showing normal use and medical need rather than misuse or neglect.
    • For lost/stolen claims, include police reports or member attestations as required by the plan.
    Denial Risk

    Documented high complication and revision risks for bone‑anchored prostheses

    Bone‑anchored transfemoral prostheses have reported high rates of revisions, infections (including osteomyelitis), and mechanical complications; include these risk data in the authorization and informed consent and expect payor scrutiny.

    • Cite published implant survival, revision‑free and infection rates when presenting justification.
    • Provide plan for infection monitoring, complication management, and rehabilitation when sought.
    Denial Risk

    Risk of denial due to insufficient or low‑quality evidence

    Insufficient or low‑quality evidence for some devices and long‑term outcomes may lead to denials when strong comparative evidence or documented functional benefit are not provided.

    • Provide high‑quality evidence or objective pre/post trial data to address evidence gaps cited in the policy.
    • Expect denials when requests rely solely on small observational studies without clear functional benefit.
    Note

    Verify member benefit and applicable mandates before approval

    Always reference the member‑specific benefit plan document and any applicable federal/state mandates when making coverage decisions; conflicts are governed by the member's plan.

    • Document the governing member plan and any applicable mandates with the request.
    • If Medicare Advantage applies, note absence or presence of NCD/LCD guidance and cite MAO rationale if used.
    Note

    Clinical Background and Scope

    Background: Lower extremity prostheses are provided across amputation levels to restore mobility. Functional classification using K0–K4 (MFCL) guides component selection, and advanced devices are evaluated relative to these functional levels when assessing potential benefit.

    Key Definitions and Terms

    Activities of Daily Living (ADLs)
    DefinitionBasic tasks people need to function and interact, including bathing, grooming, dressing, toilet use, eating, and physical ambulation.
    Purpose in policyUsed as outcome measures and functional context when assessing need for prosthetic devices and trial fitting results.
    ExamplesBathing, dressing, toileting, eating, grooming, and ambulation on level surfaces.
    Instrumental Activities of Daily Living (IADLs)
    DefinitionHigher-level cognitive and complex activities related to independent living such as shopping, transportation, meal preparation, housecleaning, managing finances, and managing medications.
    Role in assessmentAssesses community living and independence relevant to prosthetic goals and functional classification.
    ExamplesShopping, using transportation, preparing meals, housekeeping, managing finances and medications.
    CMS Modifiers/Medicare Functional Classification Level (MFCL) K0–K4
    ScopeA clinical assessment of rehabilitation potential using modifiers K0 through K4.
    K-levels summaryK0: no ambulation potential; K1: household ambulator; K2: limited community ambulator; K3: community ambulator with variable cadence; K4: high-activity ambulator.
    Use in studies and coverageMFCL/K-levels are used to stratify study populations and to guide device suitability (e.g., evidence supports MPKs mainly for K3/K4).
    Microprocessor Controlled Ankle Foot Prosthesis definition
    DefinitionAn ankle-foot prosthesis that actively changes ankle angle and identifies slopes and stair ascent/descent using microprocessor control and sensor technology (e.g., Proprio Foot).
    FunctionProvides active ankle-angle adjustments to adapt to slopes and stairs to improve gait mechanics and user mobility.
    ClassificationConsidered a microprocessor-controlled ankle-foot device; evidence for routine coverage is limited and inconsistent per policy evidence summary.
    Microprocessor Controlled Lower Limb Prostheses definition
    DefinitionKnee prostheses with sensors and microprocessor control offering variable resistance to swing and/or stance phases to simulate normal knee function and improve gait and safety.
    CapabilitiesDynamic control via sensors to adjust resistance to cadence changes, enhance stumble recovery, and potentially improve wearer confidence and safety.
    ExamplesDevices include Otto-Bock C-Leg, Ossur RheoKnee, Endolite Intelligent Prosthesis (among others).
    Prosthesis — definition
    DefinitionAn artificial device used to replace all or part of a missing body part intended to restore normal function.
    ScopePolicy applies to external prosthetic devices; fully implanted devices are covered under medical/surgical benefits, not this external prosthetics policy.
    Common usesHelps single-limb amputees achieve ambulation on level/uneven surfaces, stairs, ramps, and independence in dressing and return to work.
    Amputation levels — transtibial, transfemoral etc.
    Common levelsTranstibial (TT; below knee, BK) and transfemoral (TF; above knee, AK) are the most common lower limb amputation levels.
    Functional implicationsAmputation level guides prosthetic design and component selection (e.g., socket type, knee components).
    Policy contextClinical studies and coverage decisions often stratify outcomes by amputation level (TT vs TF) due to differing rehabilitation needs.
    OPRA — osseointegrated implant system definition
    DefinitionAn osseointegrated bone-anchored percutaneous prosthesis system that attaches a prosthesis directly to the femur and has been studied in multiple observational cohorts and case series for transfemoral amputees (OPRA).
    Evidence noteSystematic reviews and cohort studies report improved patient-reported outcomes but also high rates of infection, mechanical complications, and revisions.
    Regulatory noteOPRA Implant System received FDA premarket approval (PMA) but clinical evidence for routine coverage of transfemoral use remains limited/uncertain per Hayes reviews.
    MPK / Microprocessor-controlled knee — definition and examples
    DefinitionA prosthetic knee using microprocessor control to modulate swing and stance phases to improve gait safety and stability.
    ExamplesExamples evaluated in trials include devices such as the Otto-Bock C-Leg, Ossur RheoKnee, and Genium/Genium X3 examined in randomized and pilot trials.
    Clinical findingsEvidence shows benefit for community ambulators (MFCL K3/K4) with improved mobility, balance confidence, and reduced falls; evidence is limited for lower K-levels.
    MFCL / K-level — definition used in studies
    Definition in studiesMFCL (K-level) is a mobility classification used in studies to stratify amputee function (e.g., K2 = limited community ambulator; K3–K4 = community/high-activity ambulators).
    Use in evidenceTrials and systematic reviews frequently report outcomes by K-level; benefits of MPKs are most evident in K3/K4 and possibly selected K2 patients per trial fitting results.
    ImplicationCoverage decisions and trial-fitting recommendations reference MFCL to determine likely benefit and device suitability.
    FDA device classification — Class I device note
    Regulatory classProsthetic devices and components are classified by the FDA as Class I medical devices; manufacturers are generally exempt from premarket notification procedures unless specified.
    ExamplesClass I examples include ankle, foot, hip, knee, and socket components; mechanical or powered hand/wrist/elbow components; cables and suction valves.
    Policy noteFDA approval alone is informational and not a basis for coverage decisions under this policy.
    OPRA Implant System — PMA-approved system reference
    DeviceOPRA Implant System — an osseoanchored prosthesis system that attaches a prosthesis directly to the femur.
    Regulatory statusGranted FDA premarket approval (PMA) on December 18, 2020 (PMA P190009).
    Evidence summaryDespite PMA, systematic reviews and cohort studies show limited or unclear support for transfemoral use with high complication and revision rates reported in long-term follow-up.

    Policy Revision History

    2026-08-01policy_revisionLatest

    Updated Clinical Evidence and References sections; archived previous policy version 2026T0645M.